Conditions: Type 2 Diabetes Mellitus
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 388
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare insulin peglispro (LY2605541) to insulin glargine in Asian insulin naïve participants who have been treated with oral anti hyperglycemia medications. Participants will receive 26 weeks of treatment.

Detailed description:

Arms:
arm 1: Insulin Peglispro administered subcutaneously (SC) once daily for 26 weeks in combination with Oral Antihyperglycemic Medications (OAMs). arm 2: Insulin Glargine administered SC once daily for 26 weeks in combination with OAMs.

Interventions: intervention 1: Insulin Peglispro intervention 2: Insulin Glargine intervention 3: Oral Antihyperglycemic Medications (OAMs)
Intervention descriptions: intervention 1: Administered SC using a prefilled pen. intervention 2: Administered SC using a prefilled pen intervention 3: Administered orally

Protocol document: